Rationale for a Swedish cohort consortiumDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Department of Public Health Sciences, Stockholm University, Stockholm, Sweden; Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Department of Medical and Health Sciences, Division of Community Medicine, Linköping University, Linköping, Sweden.
Department of Medicine, Unit of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden; Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital Huddinge, Huddinge, Sweden.
Västerås Centre for Clinical Research, Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Department of Public Health and Community Medicine/Epidemiology and Social Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Odontology, School of Dentistry, Umeå University, Umeå, Sweden.
Department of Clinical Sciences, Skåne University Hospital, Malmö, Lund University, Lund, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Uppsala Clin Res Ctr UCR, Uppsala, Sweden..
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Public Health and Clinical Medicine, and Heart Center, Umeå University, Umeå, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, Helsinki University, Helsinki, Finland; Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.
Research Institute of the McGill University Health Centre, Montreal, Canada.
Uppsala Clinical Research Center (UCR), Uppsala, Sweden.
Uppsala Clinical Research Center (UCR), Uppsala, Sweden.
Uppsala Clinical Research Center (UCR), Uppsala, Sweden.
Show others and affiliations
2019 (English)In: Upsala Journal of Medical Sciences, ISSN 0300-9734, E-ISSN 2000-1967, Vol. 124, no 1, p. 21-28Article in journal (Refereed) Published
Abstract [en]
We herein outline the rationale for a Swedish cohort consortium, aiming to facilitate greater use of Swedish cohorts for world-class research. Coordination of all Swedish prospective population-based cohorts in a common infrastructure would enable more precise research findings and facilitate research on rare exposures and outcomes, leading to better utilization of study participants' data, better return of funders' investments, and higher benefit to patients and populations. We motivate the proposed infrastructure partly by lessons learned from a pilot study encompassing data from 21 cohorts. We envisage a standing Swedish cohort consortium that would drive development of epidemiological research methods and strengthen the Swedish as well as international epidemiological competence, community, and competitiveness.
Place, publisher, year, edition, pages
Taylor & Francis Group, 2019. Vol. 124, no 1, p. 21-28
Keywords [en]
Common infrastructure, epidemiological research, pilot study, rare outcomes, Swedish cohort consortium
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
URN: urn:nbn:se:oru:diva-73502DOI: 10.1080/03009734.2018.1556754ISI: 000461811100006PubMedID: 30618330Scopus ID: 2-s2.0-85059687027OAI: oai:DiVA.org:oru-73502DiVA, id: diva2:1302297
2019-04-042019-04-042020-12-01Bibliographically approved